April 9 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA RESUMES ITS PHASE 3 CLINICAL TRIAL PROGRAM
* TETRA BIO PHARMA INC - HAS DECIDED TO BRAND ITS INVESTIGATIONAL DRUG NAME FOR REGULATORY FILING PURPOSES
* TETRA BIO - TO RESUME ITS PHASE 3 CLINICAL PROGRAM IN ADVANCED CANCER PAIN PATIENTS WITH OBJECTIVE TO ASSESS HEALTH- RELATED QUALITY OF LIFE
* TETRA BIO PHARMA INC - NEW DRUG FORMERLY REFERRED TO AS PPP-001 WILL BE INVESTIGATED IN SERENITY © STUDY UNDER COMMERCIAL TRADEMARK OF CAUMZ